Markers of immune dysregulation in pediatric patients with severe bronchiolitis

Katherine Hickey1, Conor Gruber2, Sofija Buta-Panov3

  • 1Department of Pediatric Critical Care, Mount Sinai Kravis Children's Hospital, New York, NY, USA.

Journal of Human Immunity
|January 29, 2026
PubMed

Insights

Children hospitalized with bronchiolitis show distinct immune cell differences, particularly in plasmacytoid dendritic cells and eosinophils. Airway inflammation markers are also significantly altered in these patients compared to healthy controls.

Area of Science:

  • Pediatric immunology
  • Respiratory medicine
  • Cellular immunology

Background:

  • Bronchiolitis is a common pediatric respiratory illness.
  • The immunophenotype of children with bronchiolitis is not fully understood.
  • Understanding immune responses in bronchiolitis is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the unique immunophenotype of children hospitalized with bronchiolitis.
  • To compare immune cell populations and cytokine profiles between hospitalized patients and healthy controls.
  • To identify key immune factors associated with airway inflammation in pediatric bronchiolitis.

Main Methods:

  • Comparative analysis of immune cell populations (e.g., plasmacytoid dendritic cells, eosinophils) using flow cytometry.
  • Quantification of cytokine levels in patient samples.
  • Statistical analysis to determine significant differences between hospitalized children and controls.

Main Results:

  • Significant differences observed in the frequencies of plasmacytoid dendritic cells and eosinophils in hospitalized children with bronchiolitis compared to controls.
  • Elevated levels of specific cytokines involved in airway inflammation were identified in hospitalized patients.
  • The study highlights a distinct immune signature associated with severe bronchiolitis.

Conclusions:

  • Children with bronchiolitis present a unique immunophenotype characterized by altered dendritic cell and eosinophil populations.
  • Specific cytokines linked to airway inflammation are significantly different in hospitalized pediatric patients.
  • These findings contribute to understanding the immunological basis of bronchiolitis and may inform future treatment strategies.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
259
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
301
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
223
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
291
What is the Immune System?01:38

What is the Immune System?

Overview
127.7K
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
83.8K